No Data
No Data
Hunan Hansen Pharmaceutical (002412.SZ): Pharmaceutical production license changed with new production scope of "Class II Psychotropic Drugs (Hydrobromide R-Mephenytoin Granules)".
On August 8th, Gelunhui reported that Hunan Hansen Pharmaceutical (002412.SZ) has recently completed the change registration of the Pharmaceutical Production License and obtained the Pharmaceutical Production License issued by the Hunan Provincial Drug Administration. The scope of production has been added to include the production of the second-class psychotropic drug (hydrobromide right-methylmorpholine granules). Other content remains unchanged.
Hunan Hansen Pharmaceutical's Gets Nod to Make Changes to Iopamidol Injection
Hanson Pharmaceuticals (002412.SZ): The company's planting site has not yet planted Baishu
Gelonghui May 16 | Hanson Pharmaceuticals (002412.SZ) said on the investor interactive platform that the company's planting site has not yet planted Baishu.
Hanson Pharmaceuticals (002412.SZ): Net profit of 58.2647 million yuan in the first quarter increased 5.81% year-on-year
Gelonghui, April 27丨Hanson Pharmaceuticals (002412.SZ) released its report for the first quarter of 2024, with operating income of 254 million yuan, up 1.54% year on year; net profit attributable to shareholders of listed companies was 58.2647 million yuan, up 5.81% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 55.208 million yuan, up 5.07% year on year; basic earnings per share were 0.1,158 yuan
Hanson Pharmaceuticals (002412.SZ): No overseas sales of the company's products
Gelonghui, Feb. 27丨Hanson Pharmaceuticals (002412.SZ) said on the investor interactive platform that the company's leading products include Simo soup oral liquid, ginkgo biloba capsules, shokuquan capsules, Tianma Xingneng capsules (Yongzitang products), etc., and the company's products have not been sold overseas. Currently, research projects include the generic drug development project for engagliflozin tablets and the development and research of the new traditional Chinese medicine cistanche granules (tentative name).
Hanson Pharmaceuticals (002412.SZ): The recent wildfires did not affect the Tianma planting site
Gelonghui, Feb. 27丨Hanson Pharmaceuticals (002412.SZ) said on the investor interactive platform that the company built the native black hemp demonstration planting base in Xiaocaoba, Zhaotong, is a model for driving farmers by signing contracts. The recent wildfires did not affect the Tianma planting site.
No Data